Trial intelligence / Profile preview

Gentamicin for prevention of cesarean section wound infection

IRCT20200126046261N1Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Aug 2020
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of gentamicin in surgical site infection (SSI), sponsored by Mazandaran University of Medical Sciences. Started Aug 2020; status: completed.

02

Drugs

gentamicin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on IRCT20200126046261N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200126046261N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call